HOME >> MEDICINE >> NEWS
Mayo Clinic study finds heart transplant patients benefit from new approach to immunosuppression

ROCHESTER, Minn. -- A new immunosuppression regimen for heart transplant patients can improve kidney function and prevent transplant coronary artery disease, according to two new Mayo Clinic studies. Mayo researchers will report their findings on April 26 at The International Society for Heart & Lung Transplantation Annual Meeting and Scientific Session in San Francisco.

Heart transplant patients are required to take daily immunosuppressive medication to prevent their body from rejecting the transplanted organ. Standard practice has been to treat patients primarily with calcineurin inhibitors. However, calcineurin inhibitors are a major cause of kidney dysfunction and do not prevent transplant coronary artery disease, a rapidly progressing coronary disease that develops in many heart transplant recipients and greatly limits long-term survival.

"Immunosuppression for heart transplant patients using calcineurin inhibitors has been essentially unchanged for 25 years, and the results have not been ideal," says Sudhir Kushwaha, M.D., the lead author and a cardiologist at Mayo Clinic. "Five to 10 years post-transplant, 10 percent of patients are on dialysis or need a kidney transplant. And 10 years post-transplant, 50 percent of patients are either waiting for another heart transplant because of coronary artery disease or have died as a result of it."

Dr. Kushwaha and a team of Mayo Clinic researchers collaborated to study alternative options for immunosuppression, using sirolimus, an anti-proliferative immunosuppression drug with potent anti-rejection properties.

One study involving 78 heart transplant patients over four years found that gradually transitioning stable patients from calcineurin inhibitors to sirolimus showed consistent improvement of kidney function. There was no increase in rejection of the transplanted heart and no difference in heart function.

A second study found gradual transition to sirolimus
'"/>

Contact: Elizabeth Rice
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
26-Apr-2007


Page: 1 2

Related medicine news :

1. Clinical data suggest potential versatility of ALIMTA-based regimens in lung cancer
2. Susan G. Komen for the Cure and American Society of Clinical Oncology partner in national initiative
3. Clinical review -- A psychological approach to the management of irritable bowel syndrome
4. NHLBI Asthma Clinical Research Networks and ALA ACRC Network to present at ATS 2007
5. New Mayo Clinic MRI technology enables noninvasive liver diagnoses
6. Clinical trial data for Perforomist Inhalation Solution presented at International ATS Conference
7. Elsevier launches the Clinics on ScienceDirect
8. Clinical guidelines for blood conservation during cardiac procedures developed
9. Clinical trial data for Perforomist Inhalation Solution to be presented at ATS on May 20, 2007
10. Mayo Clinic research in cardiovascular disease presented at Experimental Biology 2007
11. Clinical trial coordinators need more financial conflict-of-interest training

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2020)... PLAINS, N.J. (PRWEB) , ... March 27, 2020 ... ... has been reviewed and approved by NJ Top Docs. Dr. Kubeck has been ... American Board of Orthopaedic Surgery and specializes in Spinal Surgery. , Dr. ...
(Date:3/27/2020)... ... ... time of global distress and concern about the impact of COVID-19, T1 Payments , ... Support Fund in an effort to assist hospitality workers whose jobs have been compromised ... in the food service , hotel and other major industries across the ...
(Date:3/22/2020)... ... March 21, 2020 , ... TriageLogic, ... that hospitals, medical organizations, and health centers can use for patient care during ... pandemic, many medical professionals are working around the clock to implement emergency support ...
(Date:3/20/2020)... ... March 20, 2020 , ... My heart goes out to those across our ... lost a loved one recently through similar circumstances - underlying conditions compounded by a ... felt a gamut of negative emotions just like many have: fear, anxiety, uncertainty. In ...
(Date:3/20/2020)... WILMINGTON, Del. (PRWEB) , ... March 21, 2020 ... ... from the healthcare and legal communities together for a day of live discussion ... topics including patient advocacy and ethics, telemedicine, whistleblower laws, the role of boards, ...
Breaking Medicine News(10 mins):
(Date:3/27/2020)... ... March 27, 2020 , ... ... is privileged to present Dr. Timothy Katzen as a leading weight-loss and Body ... Living partnership. , Haute Beauty offers a prominent collective of leading doctors nationwide. ...
(Date:3/20/2020)... ... March 20, 2020 , ... Despite the presence of the lone ... and the Gulf of Mexico are low, and it might be due to the ... time at the 2020 Annual Meeting of the American Academy of Allergy, Asthma & ...
(Date:3/20/2020)... ... 2020 , ... On March 19, 2020 Amramp installed a wheelchair ramp to ... The ramp and platforms helped access the large intake triage trailer in the parking ... install ramps that provide access to medical facilities and individual homes. This service enables ...
Breaking Medicine Technology:
Cached News: